Orient Europharma Co

Orient Europharma Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Orient Europharma Co (4120.TWO) as of Oct 28, 2026 is -9.89. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -36.41 — a change of -72.84% (higher).

EV/FCF

-9.89

YoY

-72.84%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Orient Europharma Co is 2025 -9.89 . EV/FCF (Enterprise Value to Free Cash Flow) of Orient Europharma Co was 2024 -36.41 . It decreases by -72.84% higher compared to the previous year.

The Orient Europharma Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
177.10 TWD
Jan 1, 2019
58.59 TWD
Jan 1, 2020
16.59 TWD
Jan 1, 2021
-5.42 TWD
Jan 1, 2022
-10.32 TWD
Jan 1, 2023
-240.69 TWD
Jan 1, 2024
-36.41 TWD
Jan 1, 2025
-9.89 TWD
The Orient Europharma Co EV/FCF history
YEAREV/FCFYoY
-9.89-72.84%
-36.41-84.87%
-240.69+2,232.09%
-10.32+90.38%
-5.42-132.68%
16.59-71.69%
58.59-66.92%
177.10+764.23%
20.49-146.50%
-44.07-496.32%
11.12-49.13%
21.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd manufactures and trades western medicine, health food, and cosmetics. The company operates in the nutritious healthcare products and medical cosmetic products segment, offering infant milk powders, nutritious products, and functional healthcare products. It also provides dermatological preparations, medical hair care series, organic skin care series, and medical make-up products. In the western drugs segment, the company supplies products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases, and asthma. The company's primary customers include consumers seeking healthcare solutions and beauty products. Its products are sold under the company's own brand, targeting health-conscious individuals and those requiring medical-grade skincare and pharmaceuticals. The firm's segments focus on delivering specialized products for specific health conditions and cosmetic needs. Orient Europharma Co Ltd generates revenue through the sale of its manufactured and traded products across multiple segments. The nutritious healthcare products segment contributes to sales of infant milk powders and functional healthcare items, while the medical cosmetic products segment drives sales of dermatological and organic skincare lines. The western drugs segment supports revenue through pharmaceuticals for chronic and acute medical conditions. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Orient Europharma Co is -9.89 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Orient Europharma Co changed from -36.41 to -9.89, representing a -72.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Orient Europharma Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Orient Europharma Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Orient Europharma Co